Advent Gains High-Potential ART Business Through Bharat Buy
Deal Gives Exit To Other PE Groups
With a majority stake in Bharat Serums, Advent gains access to biologics in gynecology and high-potential assisted reproductive technology. The deal also provides an exit to two other PE funds - OrbiMed and Kotak.
